Cell line · CVCL_0604
B16-F0
Cancer cell line, Mus musculus. Mouse melanoma. 14 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. B16-F0. Cell lines, record CVCL_0604. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0604
On this page
Cell line
As Cellosaurus gives it.
- Name
- B16-F0
- Accession
- CVCL_0604
- RRID
- RRID:CVCL_0604
- Synonyms
- B16/F0, B16F0
- Species
- Mus musculus (Mouse)
- Sex
- Male
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Mouse melanoma (NCIt C21790)
- Derived from
- Skin (in situ)
- Parent
- B16 (CVCL_F936)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers14
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Identification of siRNA silencing TGFβ1 and VEGFR2 and utility of the combination in targeting immune modulation and angiogenesis in treating melanoma in vivo. | NAR Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7. | Biol Open | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 40661388 | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score. | Cell Death Discov | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Gold Nanostars Obviate Limitations to Laser Interstitial Thermal Therapy (LITT) for the Treatment of Intracranial Tumors. | Clin Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| ARMS-NF-κB signaling regulates intracellular ROS to induce autophagy-associated cell death upon oxidative stress. | iScience | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Data-driven learning how oncogenic gene expression locally alters heterocellular networks. | Nat Commun | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression. | iScience | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Pulsed-Focused Ultrasound Slows B16 Melanoma and 4T1 Breast Tumor Growth through Differential Tumor Microenvironmental Changes. | Cancers (Basel) | 2021 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 14
See all 14 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | B16 | CVCL_F936 | Cell lines | |
| Derived from it | B16-F0-Luc | CVCL_4W99 | Cell lines | |
| Derived from it | B16-F1 | CVCL_0158 | Cell lines |
Cell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0604
GET https://conductscience.org/api/cell-lines/v1/CVCL_0604/problems